King Pharmaceuticals Canada has launched new EpiPen and EpiPen Jr (0.3 and 0.15mg epinephrine) auto-injectors, featuring an enhanced design and automatic needle protection.
Subscribe to our email newsletter
King Pharmaceuticals Canada claimed that the new EpiPen is now the only epinephrine auto-injector with built-in needle protection before, during, and after use. The new EpiPen also features a new, easy-grip body, easy-to-read instructions as well as contrasting colors for easy orientation to the needle end.
The new EpiPen’s automatic needle protection feature prevents access to the needle end after use. When the EpiPen is removed from the injection site, the needle cover automatically extends to cover the injection needle. The user does not see the needle before, during or after injection.
The new EpiPen auto-injector includes the following features: an ergonomically designed, easier-to-grasp oval barrel featuring illustrated instructions to promote proper use; carrier with one-step, flip-top cap; contrasting color-coded design; fully integrated needle protection; and visual indicator reveals if the auto-injector has been used.
King Pharmaceuticals Canada said that the basic internal function of the original EpiPen that users have come to rely on remains unchanged in the new design, including two-step activation, dosage (EpiPen 0.3 mg and EpiPen Jr. 0.15 mg), needle gauge, injection depth, expiry period and price.
Susan Waserman, allergist/clinical immunologist and professor of medicine at McMaster University, said: “The prompt and correct administration of epinephrine during a severe allergic reaction can help save lives. Any advances in auto-injector technology that simplify the process will provide an even greater level of safety for those managing anaphylaxis.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.